Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ASP Isotopes (ASPI) Research & Development (2023 - 2025)

Historic Research & Development for ASP Isotopes (ASPI) over the last 3 years, with Q3 2025 value amounting to $3.1 million.

  • ASP Isotopes' Research & Development rose 19953.3% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year increase of 28725.56%. This contributed to the annual value of $3.1 million for FY2024, which is 31054.88% up from last year.
  • As of Q3 2025, ASP Isotopes' Research & Development stood at $3.1 million, which was up 19953.3% from $879925.0 recorded in Q2 2025.
  • In the past 5 years, ASP Isotopes' Research & Development registered a high of $3.1 million during Q3 2025, and its lowest value of $65168.0 during Q4 2023.
  • For the 3-year period, ASP Isotopes' Research & Development averaged around $855616.9, with its median value being $473302.0 (2024).
  • Data for ASP Isotopes' Research & Development shows a peak YoY increase of 207299.29% (in 2024) and a maximum YoY decrease of 376.2% (in 2024) over the last 5 years.
  • Over the past 3 years, ASP Isotopes' Research & Development (Quarter) stood at $65168.0 in 2023, then skyrocketed by 2072.99% to $1.4 million in 2024, then surged by 118.81% to $3.1 million in 2025.
  • Its Research & Development was $3.1 million in Q3 2025, compared to $879925.0 in Q2 2025 and $1.5 million in Q1 2025.